Trial NCT02399917

View at ClinicalTrials.gov 
Org. Study IDs: 2014-0862
Secondary IDs: 2014-0862 NCI-2015-00678 P30CA016672

Last trial update was posted on 2019-09-24

MeSH Interventions

Azacitidine

MeSH Conditions

Leukemia Leukemia, Biphenotypic, Acute Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes

Other Conditions

Acute Biphenotypic Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Stopping Reasons

This study was terminated early due to response rates not meeting the anticipated minimum of 30%.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID